April 2023 in “Journal of Investigative Dermatology” This study found that the type 2 cytokines IL-4 and IL-13 may amplify Staphylococcus aureus-induced inflammation and barrier disruption in atopic dermatitis, potentially worsening skin defense against this bacterium.
7 citations
,
March 2021 in “Journal of Investigative Dermatology” In this study, the authors observed that Staphylococcus aureus lipase gehB is crucial for bacterial penetration of hair follicles in mice, implicating lipases in inflammation and skin damage.
January 2026 in “British Journal of Dermatology” In this study, distinct immune and cellular profiles were observed in adults with atopic dermatitis associated with high levels of Staphylococcus aureus, including increased proinflammatory T cells and markers of skin barrier impairment, pointing to potential therapeutic targets for managing these interactions.
April 2018 in “Journal of Investigative Dermatology” In this study, prophylactic treatment with a neutralizing monoclonal antibody against α-toxin reduced wound sizes and bacterial burden while enhancing healing in both non-diabetic and diabetic mice with S. aureus skin infections.
December 2004 in “Microbial Ecology in Health and Disease” This study found that Pityriasis amiantacea was associated with Staphylococcus aureus infection, especially in young women of Bedouin origin, and responded well to antibiotic and topical treatments.